Emerging treatments in lung cancer – targeting the RLIP76 molecular transporter
Lawrence E Goldfinger,1,2 Seunghyung Lee1 1Department of Anatomy and Cell Biology, The Sol Sherry Thrombosis Research Center, Temple University School of Medicine, Philadelphia, PA, USA; 2Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, PA, USA Abstract: Multidrug resistance in lung ca...
Enregistré dans:
Auteurs principaux: | Goldfinger LE, Lee S |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a8ba42b657b9401fb41fbc358a38b57e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Emerging targeted combinations in the management of breast cancer
par: Lee RJ, et autres
Publié: (2013) -
Emerging treatment options in the management of non-small cell lung cancer
par: Filosso PL, et autres
Publié: (2011) -
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
par: Dana S. Neel, et autres
Publié: (2017) -
Non-small cell lung cancer: the era of targeted therapy
par: Antonoff MB, et autres
Publié: (2012) -
Epiregulin as a therapeutic target in non-small-cell lung cancer
par: Sunaga N, et autres
Publié: (2015)